Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

Androgen deprivation therapy (ADT) is the longstanding treatment for advanced prostate cancer (PC) because androgen receptor (AR) is the key therapeutic vulnerability for this disease. Bipolar androgen therapy (BAT) — the rapid cycling of supraphysiologic androgen (SPA) and low serum testosterone le...

Descripción completa

Detalles Bibliográficos
Autores principales: Peinetti, Nahuel, Bilusic, Marijo, Burnstein, Kerry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711867/
https://www.ncbi.nlm.nih.gov/pubmed/36453547
http://dx.doi.org/10.1172/JCI165357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711867/
https://www.ncbi.nlm.nih.gov/pubmed/36453547
http://dx.doi.org/10.1172/JCI165357

Ejemplares similares